Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$8.06 +0.43 (+5.64%)
At close: Nov 11, 2026 · 4:00 PM EST

Eupraxia Pharmaceuticals (EPRX) Operating Leases (2022 - 2026)

Updated

Analysis

Eupraxia Pharmaceuticals (EPRX) Operating Leases (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Eupraxia Pharmaceuticals 304.87 Mn -174.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 2.91 Mn
Jun 30, 2026 1.68 Mn
Mar 31, 2026 1.80 Mn
Dec 31, 2025 75,910.00
Sep 30, 2025 94,467.00
Sep 30, 2024 78,752.00
Jun 30, 2024 71,008.00
Mar 31, 2024 37,848.00
Dec 31, 2023 53,316.00
Dec 31, 2022 51,303.00
API Access

Eupraxia Pharmaceuticals Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=EPRX&period=max&api_key=YOUR_API_KEY